Is DTCFF or JNJ a better dividend investment in 2026?

DTCFF currently yields 500.00% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: DTCFF offers higher current income.

What is the dividend yield difference between DTCFF and JNJ?

DTCFF has a forward dividend yield of 500.00% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 496.64 percentage points.

Home › Compare › DTCFF vs JNJ

DTCFF vs JNJ: Dividend Comparison 2026

DTCFF yields 500.00% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DTCFF wins by $61399.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DTCFF

● Live price

500.00%

Share price

$0.40

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$61399.52M

Annual income

$44,063,578,515.70

Full DTCFF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — DTCFF vs JNJ

📍 DTCFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DTCFF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DTCFF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DTCFF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTCFF

Annual income on $10K today (after 15% tax)

$42,500.00/yr

After 10yr DRIP, annual income (after tax)

$37,454,041,738.34/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, DTCFF beats the other by $37,454,041,034.73/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTCFF + JNJ for your $10,000?

DTCFF: 50%JNJ: 50%

100% JNJ50/50100% DTCFF

Portfolio after 10yr

$30699.77M

Annual income

$22,031,789,671.74/yr

Blended yield

71.77%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DTCFF

No analyst data

Altman Z

-31.5

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTCFF buys

JNJ buys

No recent congressional trades found for DTCFF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDTCFFJNJ

Forward yield	500.00% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$61399.52M ✓	$20.0K
Annual income after 10y	$44,063,578,515.70 ✓	$827.78
Total dividends collected	$59892.67M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DTCFF vs JNJ ($10,000, DRIP)

Year	DTCFF Portfolio	DTCFF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$60,700	$50,000.00	$10,676	$355.77	+$50.0K → DTCFF
2	$348,594	$283,644.86	$11,407	$389.39	+$337.2K → DTCFF
3	$1,895,372	$1,522,376.89	$12,198	$426.53	+$1.88M → DTCFF
4	$9,763,990	$7,735,942.00	$13,056	$467.62	+$9.75M → DTCFF
5	$47,691,977	$37,244,507.54	$13,987	$513.12	+$47.68M → DTCFF
6	$221,049,019	$170,018,603.23	$14,998	$563.56	+$221.03M → DTCFF
7	$972,993,924	$736,471,474.07	$16,098	$619.52	+$972.98M → DTCFF
8	$4,070,762,075	$3,029,658,575.98	$17,295	$681.69	+$4070.74M → DTCFF
9	$16,201,818,371	$11,846,102,950.68	$18,599	$750.82	+$16201.80M → DTCFF
10	$61,399,524,173	$44,063,578,515.70	$20,022	$827.78	+$61399.50M → DTCFF

DTCFF vs JNJ: Complete Analysis 2026

DTCFF — Stock

Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full DTCFF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this DTCFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTCFF vs SCHD DTCFF vs JEPI DTCFF vs O DTCFF vs KO DTCFF vs MAIN DTCFF vs ABBV DTCFF vs MRK DTCFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.